- Home
- RFL vs BGM Comparison
RFL vs BGM Comparison
Compare RFL & BGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFL
- BGM
- Stock Information
- Founded
- RFL 2017
- BGM 2019
- Country
- RFL United States
- BGM China
- Employees
- RFL N/A
- BGM N/A
- Industry
- RFL Real Estate
- BGM
- Sector
- RFL Finance
- BGM
- Exchange
- RFL Nasdaq
- BGM NYSE
- Market Cap
- RFL 48.4M
- BGM 52.8M
- IPO Year
- RFL N/A
- BGM 2021
- Fundamental
- Price
- RFL $1.84
- BGM $6.61
- Analyst Decision
- RFL
- BGM
- Analyst Count
- RFL 0
- BGM 0
- Target Price
- RFL N/A
- BGM N/A
- AVG Volume (30 Days)
- RFL 26.3K
- BGM 14.9K
- Earning Date
- RFL 12-12-2024
- BGM 08-14-2024
- Dividend Yield
- RFL N/A
- BGM N/A
- EPS Growth
- RFL N/A
- BGM N/A
- EPS
- RFL N/A
- BGM N/A
- Revenue
- RFL $637,000.00
- BGM $29,870,461.00
- Revenue This Year
- RFL N/A
- BGM N/A
- Revenue Next Year
- RFL N/A
- BGM N/A
- P/E Ratio
- RFL N/A
- BGM N/A
- Revenue Growth
- RFL 128.32
- BGM N/A
- 52 Week Low
- RFL $1.29
- BGM $1.78
- 52 Week High
- RFL $2.50
- BGM $8.96
- Technical
- Relative Strength Index (RSI)
- RFL 46.69
- BGM 38.95
- Support Level
- RFL $1.74
- BGM $6.23
- Resistance Level
- RFL $1.96
- BGM $7.82
- Average True Range (ATR)
- RFL 0.10
- BGM 0.43
- MACD
- RFL -0.01
- BGM -0.13
- Stochastic Oscillator
- RFL 40.00
- BGM 24.19
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company is a significant investor in two clinical stage oncology companies, Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd.
About BGM QILIAN INTERNATIONAL HLDG GROUP LTD
BGM Group Ltd formerly, Qilian International Holding Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium.